2025

• Hofsli, Eva; Sætrom, Pål; Ness-Jensen, Eivind; Surcel, Helja-Marja; Mjelle, Robin. (2025) Can circulating microRNAs predict colorectal cancer? Results from a nested case–control study of pre-diagnostic serum samples from two prospective biobanks. BMC Cancer
  Academic article

2024

• Mjelle, Robin; Kristensen, Are Korsnes; Solheim, Tora S; Westvik, Ganna Surzhykova; Elvebakken, Hege; Hofsli, Eva. (2024) Serum small RNAs in metastatic colorectal cancer predict response to chemotherapy and characterize high-risk patients. Molecular Cancer
  Letter to the editor
• Hatlevoll, Ingunn; Kristensen, Are Korsnes; Solheim, Tora S; Elvebakken, Hege; Salvesen, Øyvind Olav; Oldervoll, Line Merethe. (2024) Do older patients with colorectal cancer experience more deterioration in health-related quality of life than younger patients during the first year of palliative chemotherapy? A prospective real-world observational study. Journal of Geriatric Oncology
  Academic article
• Ree, Anne Hansen; Saltyte Benth, Jurate; Hamre, Hanne Mari; Kersten, Christian; Hofsli, Eva; Guren, Marianne. (2024) First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer—the randomised METIMMOX trial. British Journal of Cancer
  Academic article
• Ree, Anne Hansen; Høye, Eirik; Esbensen, Qin Ying; Røberg Beitnes, Ann-Christin; Negård, Anne; Bernklev, Linn. (2024) Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade. Oncoimmunology
  Academic article
• Elvebakken, Hege; Venizelos, Andreas; Perren, Aurel; Couvelard, Anne; Lothe, Inger Marie Bowitz; Hjortland, Geir Olav. (2024) Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms. British Journal of Cancer
  Academic article

2023

• Elvebakken, Hege; Sørbye, Halfdan; Hofsli, Eva; Hoff, Dag Arne Lihaug. (2023) High-grade digestive neuroendocrine neoplasms. Impact of genetic alterations and morphologicalcharacteristics on outcome of first-line palliative chemotherapy. Norges teknisk-naturvitenskapelige universitet Doctoral theses at NTNU
  Doctoral dissertation
• Hægermark , Emil Carl Richard Aale ; Kongshaug, Nina Anita; Raj, Sunil Xavier; Hofsli, Eva; Faxvaag, Arild. (2023) Design, Development, and Evaluation of an mHealth App for Reporting of Side Effects During Cytostatic Treatment: Usability Test and Interview Study. JMIR Formative Research
  Academic article
• Liposits, Gabor; Winther, Stine B.; Ryg, Jesper; Skuladottir, Halla; Möller, Sören; Hofsli, Eva. (2023) The effect of BRAF^V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer – A post-hoc exploratory analysis of the randomized NORDIC9-study. Journal of Geriatric Oncology
  Academic article
• Haram, Karin Margrete; Hansen, Rune; Bouget, David Nicolas Jean-Marie; Myhre, Ola Finneng; Davies, Catharina de Lange; Hofsli, Eva. (2023) Treatment of Liver Metastases With Focused Ultrasound and Microbubbles in Patients With Colorectal Cancer Receiving Chemotherapy. Ultrasound in Medicine and Biology
  Academic article
• Venizelos, Andreas; Sorbye, Halfdan; Elvebakken, Hege; Perren, Aurel; Lothe, Inger Marie Bowitz; Couvelard, Anne. (2023) Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-Related Cancer
  Academic article
• Knappskog, Stian; Grob, Tobias; Venizelos, Andreas; Amstutz, Ursula; Hjortland, Geir Olav; Lothe, Inger Marie Bowitz. (2023) Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma. JCO Precision Oncology (JCO PO)
  Academic article

2022

• Larsen, Stein Gunnar; Goscinski, Mariusz Adam; Dueland, Svein; Steigen, Sonja Eriksson; Hofsli, Eva; Kristensen, Annette Torgunrud. (2022) Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients. British Journal of Cancer
  Academic article
• Meltzer, Sebastian; Negård, Anne; Bakke, Kine Mari; Hamre, Hanne Mari; Kersten, Christian; Hofsli, Eva. (2022) Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer. British Journal of Cancer
  Academic article
• Liposits, Gabor; Skuladottir, Halla; Ryg, Jesper; Winther, Stine Brændegaard; Möller, Sören; Hofsli, Eva. (2022) The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, dNLR, YKL-40, and IL-6) in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy—The Randomized NORDIC9-Study. Journal of Clinical Medicine
  Academic article
• Knappskog, Stian; Sorbye, Halfdan; Grob, Tim; Venizelos, Andreas; Amstutz, Ursula; Hjortland, Geir Olav. (2022) Mutation spectrum in liquid versus solid biopsies from advanced digestive neuroendocrine carcinoma patients. Annals of Oncology
  Abstract
• Liposits, Gabor Isivan; Ryg, Jesper; Skuladottir, Halla; Winther, Stine B.; Möller, Sören; Hofsli, Eva. (2022) Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – The randomized NORDIC9-study. Journal of Geriatric Oncology
  Academic article
• Falk, Philip; Severin, Mira; Berglund, Åke; Guren, Marianne; Hofsli, Eva; Österlund, Pia. (2022) Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer. Cancer Treatment and Research Communications
  Academic article

2021

• Liposits, Gabor; Eshoj, Henrik; Möller, Sören; Winther, Stine Brændegaard; Skuladottir, Halla; Ryg, Jesper. (2021) Quality of life in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy—the randomized NORDIC9-study. Cancers
  Academic article
• Venizelos, Andreas; Elvebakken, Hege; Perren, Aurel; Nikolaienko, Oleksii; Deng, Wei; Lothe, Inger Marie Bowitz. (2021) The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-Related Cancer
  Academic article
• Larsen, Stein Gunnar; Goscinski, Mariusz Adam; Dueland, Svein; Steigen, Sonja Eriksson; Hofsli, Eva; Torgunrud, Annette . (2021) Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients. British Journal of Cancer
  Academic article
• Hatlevoll, Ingunn; Skolbekken, John-Arne; Oldervoll, Line Merethe; Wibe, Arne; Hofsli, Eva. (2021) Colorectal cancer patients’ experiences with supervised exercise during adjuvant chemotherapy—A qualitative study. Scandinavian Journal of Medicine & Science in Sports
  Academic article
• Kongshaug, Nina; Skolbekken, John-Arne; Faxvaag, Arild; Hofsli, Eva. (2021) Cancer Patients’ Perceived Value of a Smartphone App to Enhance the Safety of Home-Based Chemotherapy: Feasibility Study. JMIR Formative Research
  Academic article

2020

• Hatlevoll, Ingunn; Oldervoll, Line Merethe; Wibe, Arne; Stene, Guro Birgitte; Stafne, Signe Nilssen; Hofsli, Eva. (2020) Physical exercise during adjuvant chemotherapy for colorectal cancer - a non-randomized feasibility study. Supportive Care in Cancer
  Academic article
• Mjelle, Robin; Aass, Kristin Roseth; Sjursen, Wenche; Hofsli, Eva; Sætrom, Pål. (2020) sMETASeq: combined profiling of microbiota and host small RNAs. iScience
  Academic article

2019

• Mjelle, Robin; Sjursen, Wenche; Thommesen, Liv; Sætrom, Pål; Hofsli, Eva. (2019) Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location. BMC Cancer
  Academic article
• Winther, Stine Brændegaard; Liposits, Gabor Isivan; Skuladottir, Halla; Hofsli, Eva; Shah, Carl-Henrik; Poulsen, Laurids Østergaard. (2019) Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial. The Lancet Gastroenterology and Hepatology
  Academic article

2017

• Mjelle, Robin; Sellæg, Kjersti; Sætrom, Pål; Thommesen, Liv; Sjursen, Wenche; Hofsli, Eva. (2017) Identification of metastasis-associated microRNAs in serum from rectal cancer patients. OncoTarget
  Academic article

2015

• Guren, Marianne; Kørner, Hartwig; Pfeffer, Frank; Myklebust, Tor Åge; Eriksen, Morten Tandberg; Edna, Tom-Harald. (2015) Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010. Acta Oncologica
  Academic article

2013

• Sjursen, Wenche; Halvorsen, Henrik; Hofsli, Eva; Bachke, Siri; Berge, Åsa; Engebretsen, Lars Fredri. (2013) Mutation screening in a Norwegian cohort with pheochromocytoma. Familial Cancer
  Academic article
• Sorbye, Halfdan; Welin, Staffan; Langer, Seppo W.; Vestermark, Lene Weber; Holt, Nanna; Osterlund, Pia. (2013) Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study. Annals of Oncology
  Academic article
• Sorbye, Halfdan; Welin, Staffan; Langer, Seppo; Vestermark, Lena; Holt, Nanna; Osterlund, Pia. (2013) Ki-67 Proliferative Index Predicts Response to Chemotherapy and Survival in 252 Patients with High-Grade Gastrointestinal Neuroendocrine Carcinoma (WHO G3). Pancreas
  Abstract
• Hofsli, Eva; Sjursen, Wenche; Prestvik, Wenche S; Johansen, Jostein; Rye, Morten Beck; Tranø, Gerd. (2013) Identification of serum microRNA profiles in colon cancer. British Journal of Cancer
  Academic article

2012

• Sorbye, Halfdan; Welin, Staffan; Langer, Seppo W.; Vestermark, Lene Weber; Holt, Nanna; Osterlund, Pia J.. (2012) Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal poorly differentiated neuroendocrine carcinoma: The NORDIC NEC study. Journal of Clinical Oncology
  Abstract
• Tveit, Magne Kjell; Guren, Tormod Kyrre; Glimelius, Bengt; Pfeiffer, Per; Sorbye, Halfdan; Pyrhonen, Seppo. (2012) Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: The NORDIC-VII Study. Journal of Clinical Oncology
  Academic article

2010

• Tessem, May-Britt; Selnæs, Kirsten Margrete; Sjursen, Wenche; Tranø, Gerd; Giskeødegård, Guro F.; Bathen, Tone Frost. (2010) Discrimination of Patients with Microsatellite Instability Colon Cancer using H-1 HR MAS MR Spectroscopy and Chemometric Analysis. Journal of Proteome Research
  Academic article
• Tranø, Gerd; Sjursen, Wenche; Wasmuth, Hans; Hofsli, Eva; Vatten, Lars Johan. (2010) Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study. British Journal of Cancer
  Academic article
• Marienhagen, Kirsten; Helland, Åslaug; Nordberg, Terje; Guren, Marianne Grønlie; Hofsli, Eva. (2010) Hva mener norske onkologer om sin arbeidssituasjon?. Tidsskrift for Den norske legeforening (Tidsskriftet)
  Academic article

2009

• Tranø, G; Wasmuth, HH; Sjursen, Wenche; Hofsli, E; Vatten, Lars Johan. (2009) Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population-based study. Colorectal Disease
  Academic article

2008

• Hofsli, Eva; Wheeler, Tom Even; Langaas, Mette; Lægreid, Astrid; Thommesen, Liv. (2008) Identification of novel neuroendocrine-specific tumour genes. British Journal of Cancer
  Academic article
• Hofsli, Eva; Wheeler, Tommy L.; Langaas, Mette; Lægreid, Astrid; Thommesen, Liv. (2008) Identification of novel neuroendocrine-specific tumour genes. British Journal of Cancer
  Academic article

2005

• Hofsli, Eva; Thommesen, Liv; Yadetie, Fekadu; Langaas, Mette; Sandvik, Arne K.; Lægreid, Astrid. (2005) Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells. British Journal of Cancer
  Academic article
• Hofsli, Eva; Thommesen, Liv; Yadetie, Fekadu; Langaas, Mette; Kusnierczyk, Waclaw; Falkmer, Ursula. (2005) Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells. British Journal of Cancer
  Academic article

2002

• Hofsli, Eva; Nørsett, Kristin; Sandvik, Arne Kristian; Lægreid, Astrid. (2002) Expression of chromogranin A and somatostatin receptors in pancreatic AR42J cells. Molecular and Cellular Endocrinology
  Academic article

2000

• Thommesen, Liv; Nørsett, Kristin; Hofsli, Eva; Sandvik, AK; Lægreid, Astrid. (2000) Regulation of inducible cAMP early repressor expression by gastrin and cholecystokinin in the pancreatic cell line AR42J. Journal of Biological Chemistry
  Academic article

1989

• Paulsson, Y; Austgulen, Rigmor; Hofsli, E; Heldin, CH; Westermark, B; Nissen-Meyer, J. (1989) Tumor necrosis factor-induced expression of platelet-derived growth factor A-chain messenger RNA into fibroblasts. Experimental Cell Research
  Academic article

1988

• Waage, A; Hofsli, E; Austgulen, Rigmor. (1988) Tumor nekrose faktor. En oversikt. Tidsskrift for Den norske legeforening (Tidsskriftet)
  Academic article
• Nissen-Meyer, J; Hofsli, E; Espevik, Terje; Austgulen, Rigmor. (1988) Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes. Natural immunity and cell growth regulation
  Academic article

1987

• Hofsli, E; Austgulen, Rigmor; Nissen-Meyer, J. (1987) Lymphotoxin-induced growth stimulation of diploid human fibroblasts in the presence and absence of interferon gamma. Scandinavian Journal of Immunology
  Academic article